DMAC 10-Q: SEC filing

DiaMedica Therapeutics

Filed with the SEC on · accession 0001437749-26-036602

DMAC filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. DiaMedica Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures. The stock moved -3.4% by the first close after the filing.

Summary of the filing

DiaMedica Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures. No specific material corporate event is identifiable from the filing text provided.

Key details

FilerDiaMedica Therapeutics Inc.

How DMAC stock reacted

Close before

$9.66

Nov 11, 2026

First close after

-3.42%

$9.33

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DMAC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DMAC?

Click here

Frequently asked questions

What did DMAC file with the SEC on Nov 12, 2026?

DMAC filed a 10-Q (SEC filing). DiaMedica Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures. No specific material corporate event is identifiable from the filing text provided.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did DMAC stock react to this filing?

DMAC closed at $9.66 before the filing and $9.33 on Nov 12, 2026 (-3.42%).

Other DMAC SEC filings

Get alerts when DMAC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days